Notes archive.
Almondz Global Securities revenue climbs 34%, but profit slips
The company eyes June for biofuel procurement contracts in Odisha as infrastructure advisory growth targets reach 18-20%.
SMS Pharmaceuticals hits ₹87.61 cr profit as FY26 growth hits target
Revenue climbed 13% to ₹886.87 cr, matching earlier guidance. The board approved a dividend of ₹0.40 per share.
Triveni Turbine clocks record revenue as US data center demand spikes
Export growth is leading the charge, with the enquiry book reaching 18 GW. US-specific interest grew ten-fold during the quarter.
Asha Devi Goenka trims Kamadgiri Fashion stake to near zero
The promoter sold 45,000 shares in May, following a March exit, leaving her with just 0.15% of the company.
Symphony writes off its ₹348 cr Australian investment
A failed overseas expansion and a weak summer combine to force a ₹141 crore loss. Management has officially pulled the plug on the Australian unit.
Vaibhav Global pares growth targets as US, UK retail headwinds persist
Retailer lowers medium-term revenue growth guidance to 10-12% from mid-teens as US sales growth stalls at 1% for a third year.
Prakash Industries FY26 sales drop 13% as audit qualification persists
Annual profit fell to ₹333 cr. The auditor continues to dispute deferred tax accounting.
Century Enka lifts margin guidance as tyre-cord project slips to FY27
Management moves margin targets to 7-10% on energy savings, while the long-delayed polyester tyre cord unit hits another snag.
Minda Corporation posts record quarterly revenue of ₹1,704 cr
Profit more than doubled in Q4 as consolidated full-year revenue hit ₹6,185 cr.
Ircon profit slides 16% as board declares final dividend
The infrastructure firm reports FY26 standalone profit of ₹618.45 cr, down from ₹737.59 cr in the prior year.
Sun Pharma posts 26% Q4 profit growth and readies tax shift
The drugmaker closed FY26 with a ₹5 final dividend, while preparing to tap a lower tax regime in the new fiscal year.
Prakash Industries FY26 profit dips to ₹333 cr
The steel and mining firm beat last year's dividend with a payout of ₹1.80 per share, even as annual profits retreated.
Shilpa Medicare profit hits ₹108 cr as pharma operations turn around
Consolidated net profit grew sevenfold in the March quarter while the company moved to buy a 28% stake in Neo Green Power.
Shilpa Medicare profit triples to ₹243 cr
Consolidated profits surged behind an improved operating performance and a one-time stake sale, while management targets captive energy savings.
3M India triples quarterly profit as board declares ₹506 dividend
A special dividend payout of ₹346 per share accompanies a strong finish to FY26, as the board shuffles leadership roles.
Dhanuka Agritech transcript adds no new information to FY27 guidance
A routine record of the May 19 earnings call confirms previously disclosed targets for growth and biostimulant contributions.
Endurance lands ₹1,596 cr in Indian orders, wins a ₹300 cr EV battery deal.
The auto-parts maker's Europe unit posted record quarterly margins as revenue grew 26.1% for the full year. A battery-pack contract starts production in late May.
Sun Pharmaceutical FY26 growth hits 11.9% as dividends hold steady
A routine year-end filing shows consolidated sales growth and a final ₹5 dividend, maintaining the total payout from the prior year.
Swadeshi Polytex reports FY26 profit of ₹417.57 lakhs from investments
The company remains an investment-led entity with no operating revenue.
Sanghvi Movers targets FY27 growth matching last year's 37% jump
With a ₹1,053 cr order book and Saudi operations nearing break-even, the company plans ₹590 cr of new capex for FY27.
Jubilant Pharmova posts ₹8,280 cr revenue, adds oncology client to Montreal facility
FY26 revenue grew 14% while EBITDA rose 8%. The CDMO unit added a global oncology product and is remediating its Montreal plant.
Antariksh Industries revenue slides to ₹516.66 lakhs in FY26
Audited results confirm an 88% revenue collapse and a sharp contraction in annual profits.
Credo Brands cuts margins as Mufti 2.0 pivot shifts growth to FY28
Management abandons FY27 growth targets, citing higher ad spend as it overhauls the apparel brand's retail footprint.
GPT Healthcare earnings drag as new Raipur facility losses bite
Revenue grew 15% to ₹478.5 crore, but profits slumped as the company absorbed startup costs at its newest hospital.
TTK Prestige posts 14% PAT growth on ₹2,773 cr revenue in FY26
Standalone profit rose to ₹185 crore. Consolidated bottom line jumped 45% after exceptional items, but those were already flagged.